Dopamine, time perception, and future time perspective
Open Access
- 19 July 2018
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 235 (10) , 2783-2793
Abstract
Rationale Impairment in time perception, a critical component of decision-making, represents a risk factor for psychiatric conditions including substance abuse. A therapeutic that ameliorates this impairment could be advantageous in the treatment of impulsivity and decision-making disorders. Objectives Here we hypothesize that the catechol-O-methyltransferase (COMT) inhibitor tolcapone, which increases dopamine tone in frontal cortex (Ceravolo et al Synapse 43:201–207, 2002), improves time perception, with predictive behavioral, genetic, and neurobiological components. Methods Subjects (n = 66) completed a duration estimation task and other behavioral testing in each of two sessions after receiving a single oral dose of tolcapone (200 mg) or placebo in randomized, double-blind, counterbalanced, crossover fashion. Resting state fMRI data were obtained in a subset of subjects (n = 40). Subjects were also genotyped for the COMT (rs4680) polymorphism. Results Time perception was significantly improved across four proximal time points ranging from 5 to 60 s (T(524) = 2.04, p = 0.042). The degree of this improvement positively correlated with subjective measures of stress, depression, and alcohol consumption and was most robust in carriers of the COMT Val158 allele. Using seed regions defined by a previous meta-analysis (Wiener et al Neuroimage 49:1728–1740, 2010), we found not only that a connection from right inferior frontal gyrus (RIFG) to right putamen decreases in strength on tolcapone versus placebo (p < 0.05, corrected), but also that the strength of this decrease correlates inversely with the increase in duration estimation on tolcapone versus placebo (r = − 0.37, p = 0.02). Conclusions Compressed time perception can be ameliorated by administration of tolcapone. Additional studies should be conducted to determine whether COMT inhibitors may be effective in treating decision-making disorders and addictive behaviors.Keywords
Funding Information
- U.S. Department of War (W81XWH-11-2-0145)
- National Eye Institute (EY024554)
This publication has 63 references indexed in Scilit:
- Impaired Representation of Time in Schizophrenia Is Linked to Positive Symptoms and Cognitive DemandPLOS ONE, 2013
- Dopamine, Corticostriatal Connectivity, and Intertemporal ChoiceJournal of Neuroscience, 2012
- Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive ControlBiological Psychiatry, 2011
- Neuroanatomical and Neurochemical Substrates of TimingNeuropsychopharmacology, 2010
- REVIEW: Understanding the construct of impulsivity and its relationship to alcohol use disordersAddiction Biology, 2010
- The image of time: A voxel-wise meta-analysisNeuroImage, 2010
- Impaired time perception and motor timing in stimulant-dependent subjectsDrug and Alcohol Dependence, 2007
- Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesisMedical Hypotheses, 2007
- What makes us tick? Functional and neural mechanisms of interval timingNature Reviews Neuroscience, 2005
- Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson??s DiseaseClinical Pharmacokinetics, 2002